{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:54:59Z","timestamp":1773154499594,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.antiviral.2012.07.009","type":"journal-article","created":{"date-parts":[[2012,8,6]],"date-time":"2012-08-06T13:46:52Z","timestamp":1344260812000},"page":"65-69","source":"Crossref","is-referenced-by-count":38,"title":["High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy"],"prefix":"10.1016","volume":"96","author":[{"given":"Anna","family":"Bonjoch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Echeverr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Perez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Estany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eug\u00e8nia","family":"Negredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.07.009_b0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.antiviral.2010.09.015","article-title":"Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort","volume":"88","author":"Bonjoch","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.07.009_b0010","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1097\/QAD.0b013e328340a28d","article-title":"High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study","volume":"24","author":"Bonjoch","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2012.07.009_b0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3851\/IMP1874","article-title":"Bone turnover, osteoprotegerin\/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens","volume":"16","author":"Brown","year":"2011","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2012.07.009_b0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1468-1293.2008.00691.x","article-title":"Spectrum of chronic kidney disease in HIV-infected patients","volume":"10","author":"Campbell","year":"2009","journal-title":"HIV Med."},{"key":"10.1016\/j.antiviral.2012.07.009_b0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2009.09.014","article-title":"Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine","volume":"85","author":"Cihlar","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.07.009_b0030","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/QAD.0b013e3283313c91","article-title":"HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy","volume":"23","author":"Choi","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2012.07.009_b0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.antiviral.2010.03.001","article-title":"The frequency and reasons for antiretroviral switching with specific antiretroviral associations: the SWITCH study","volume":"86","author":"Davidson","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.07.009_b0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(03)00916-8","article-title":"A population-based study of the incidence and outcomes of diagnosed chronic kidney disease","volume":"42","author":"Drey","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.antiviral.2012.07.009_b0045","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/428840","article-title":"Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment","volume":"40","author":"Gallant","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.07.009_b0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2012.07.009_b0055","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/430257","article-title":"Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America","volume":"40","author":"Gupta","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.07.009_b0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.antiviral.2009.10.016","article-title":"Understanding and managing the adverse effects of antiretroviral therapy","volume":"85","author":"Hawkins","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.07.009_b0065","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32833bee44","article-title":"Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals","volume":"24","author":"Ho","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2012.07.009_b0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ndt\/gfh658","article-title":"Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study","volume":"20","author":"Izzedine","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.antiviral.2012.07.009_b0075","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00002030-200404300-00019","article-title":"Renal safety of tenofovir in HIV treatment-experienced patients","volume":"18","author":"Izzedine","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2012.07.009_b0080","doi-asserted-by":"crossref","first-page":"e30881","DOI":"10.1371\/journal.pone.0030881","article-title":"A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy","volume":"7","author":"Kamat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2012.07.009_b0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1752-1947-2-94","article-title":"Acute renal failure in an AIDS patient on tenofovir: a case report","volume":"2","author":"Kapitsinou","year":"2008","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.antiviral.2012.07.009_b0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/labinvest.2009.14","article-title":"Tenofovir renal toxicity targets mitochondria of renal proximal tubules","volume":"89","author":"Kohler","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.antiviral.2012.07.009_b0095","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/QAD.0b013e328337b957","article-title":"CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART","volume":"24","author":"Massanella","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2012.07.009_b0100","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/QAD.0b013e3280f774ee","article-title":"Chronic renal failure among HIV-1-infected patients","volume":"21","author":"Mocroft","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2012.07.009_b0105","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1089\/aid.2007.0310","article-title":"Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients","volume":"24","author":"Munoz-Moreno","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2012.07.009_b0110","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","article-title":"Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States","volume":"13","author":"Muntner","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.antiviral.2012.07.009_b0115","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/651689","article-title":"Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications","volume":"50","author":"Negredo","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.07.009_b0120","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jac\/dkr039","article-title":"Low incidence of renal impairment observed in tenofovir-treated patients","volume":"66","author":"O\u2019Donnell","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2012.07.009_b0175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1681\/ASN.2004060447","article-title":"Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease","volume":"16","author":"Poggio","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.antiviral.2012.07.009_b0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/infdis\/jir215","article-title":"Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction","volume":"204","author":"Pushpakom","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.07.009_b0130","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study","volume":"48","author":"Rodriguez-Novoa","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.07.009_b0180","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-141-12-200412210-00009","article-title":"Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease","volume":"141","author":"Rule","year":"2004","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.antiviral.2012.07.009_b0185","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","article-title":"Association of tenofovir exposure with kidney disease risk in HIV infection","volume":"26","author":"Scherzer","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2012.07.009_b0140","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function\u2013measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2012.07.009_b0145","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":"Fanconi syndrome and renal failure induced by tenofovir: a first case report","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.antiviral.2012.07.009_b0150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/sj.ki.5002374","article-title":"Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study","volume":"72","author":"Wetzels","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.antiviral.2012.07.009_b0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/QAI.0b013e3181d05579","article-title":"Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men","volume":"55","author":"Wever","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2012.07.009_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2008.0106","article-title":"Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males","volume":"23","author":"Wood","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.antiviral.2012.07.009_b0165","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/QAD.0b013e3282ef1bb4","article-title":"Chronic kidney disease in HIV infection: an urban epidemic","volume":"21","author":"Wyatt","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2012.07.009_b0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1086\/499048","article-title":"Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions","volume":"42","author":"Zimmermann","year":"2006","journal-title":"Clin. Infect. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212001702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212001702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T19:29:57Z","timestamp":1643138997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212001702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0166354212001702"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.07.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}